Cisco CFO: Services...
Health Care: Drugs
iBio Inc. (IBIO: AMEX)
$0.38 -0.02 | -6.07%
05/20/13 - 03:58 PM ET
119.94K / 108.70K
Vol / Avg. Vol:0.41 / 0.41
Open / Prev. Close:0.38 - 0.41
Today's Range:0.38 - 1.70
52 Wk Range:n/a%
Performance YTD:TheStreet Rating:
Portfolios with IBIO
- Portfolio NameUser Type
- Usercosmo
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserBiotech88
Latest IBIO Headlines from TheStreet
- 4 Biotech Stocks Under $10 Moving Higher 10.05.12 | 08:10 am
- 5 Stocks Under $10 Setting Up to Break Out 09.13.12 | 12:09 pm
- 10 New Stocks Rated by TheStreet 08.03.11 | 02:08 pm
Press Releases for IBIO
- GE Alliance Awarded Contract To Design New Plant-based Manufacturing Facility In Brazil - PR Newswire 04.09.13 | 07:04 am
- IBio Selects Proprietary Recombinant C1 Inhibitor For Clinical Development - PR Newswire 03.26.13 | 07:03 am
- IBio Adds To IBioModulator Portfolio And Product Pipeline - PR Newswire 03.13.13 | 07:03 am
- IBio Adds New Therapeutic Antibody To Its Pipeline - PR Newswire 03.04.13 | 09:03 am
- IBio, Inc. Receives Anticipated Notice From NYSE MKT That Company Is Below Certain Continued Listing Standards - PR Newswire 03.04.13 | 09:03 am
- IBio And Caliber Biotherapeutics Establish License And Collaboration Relationship - PR Newswire 02.19.13 | 07:02 am
- IBio, Inc. Receives Approval From NYSE MKT Of Compliance Plan - PR Newswire 02.13.13 | 07:02 am
- IBio Announces At-the-Market Equity Offering - PR Newswire 02.01.13 | 09:02 am
- IBio Announces New Appointment To Board Of Directors And New Addition To Executive Management Team - PR Newswire 12.21.12 | 07:12 am
- National Institute Of Health Awards Contract To Support Use Of IBio's Proprietary Technology For Improved Anthrax Vaccine - PR Newswire 12.05.12 | 07:12 am
Partner Headlines for IBIO
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- iBio Announces Proposed Public Offering; No Amount Given - Benzinga 01.09.12 | 04:01 pm
- IBIO: Pharma Stock With Much Downside Risk And Low Upside Potential - Seeking Alpha 11.02.11 | 08:11 am
- iBio Still Overvalued; More Dilution Likely - Seeking Alpha 06.29.11 | 09:06 am
- Trading Resumes: iBio, Inc. - Benzinga 03.08.11 | 01:03 pm
- iBio Overvalued - Seeking Alpha 02.09.11 | 08:02 am
- 4 Stocks for the Aggressive Investor - Seeking Alpha 02.02.11 | 08:02 am
- iBio: A True Paradigm Shift - Seeking Alpha 01.24.11 | 09:01 am
